A citation-based method for searching scientific literature

Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg, Benjamin L Ebert. N Engl J Med 2011
Times Cited: 1036







List of co-cited articles
833 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Chris J Yoon, Peter Ellis, David C Wedge, Andrea Pellagatti,[...]. Blood 2013
57

Revised international prognostic scoring system for myelodysplastic syndromes.
Peter L Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Francesc Solé, John M Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus,[...]. Blood 2012
52

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
843
51

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
37

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
30

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
805
26

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
22

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
21

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, A Pellagatti, J S Wainscoat, E Hellstrom-Lindberg, C Gambacorti-Passerini,[...]. N Engl J Med 2011
796
20

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
R Coleman Lindsley, Wael Saber, Brenton G Mar, Robert Redd, Tao Wang, Michael D Haagenson, Peter V Grauman, Zhen-Huan Hu, Stephen R Spellman, Stephanie J Lee,[...]. N Engl J Med 2017
313
19

Clinical significance of somatic mutation in unexplained blood cytopenia.
Luca Malcovati, Anna Gallì, Erica Travaglino, Ilaria Ambaglio, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, Virginia Valeria Ferretti, Silvia Catricalà, Elisa Bono,[...]. Blood 2017
186
19

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List,[...]. Lancet Oncol 2009
18

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
Pierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, Guillermo Garcia-Manero, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Mario Cazzola, Osman Ilhan,[...]. N Engl J Med 2020
112
18

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
Rafael Bejar, Allegra Lord, Kristen Stevenson, Michal Bar-Natan, Albert Pérez-Ladaga, Jacques Zaneveld, Hui Wang, Bennett Caughey, Petar Stojanov, Gad Getz,[...]. Blood 2014
380
17

Dynamics of clonal evolution in myelodysplastic syndromes.
Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, Mikkael A Sekeres, Tomas Radivoyevitch, Hiromichi Suzuki, Bartlomiej Przychodzen, Yasunobu Nagata, Manja Meggendorfer, Masashi Sanada,[...]. Nat Genet 2017
203
17

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
Luca Malcovati, Mohsen Karimi, Elli Papaemmanuil, Ilaria Ambaglio, Martin Jädersten, Monika Jansson, Chiara Elena, Anna Gallì, Gunilla Walldin, Matteo G Della Porta,[...]. Blood 2015
230
16

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.
Bruce D Cheson, Peter L Greenberg, John M Bennett, Bob Lowenberg, Pierre W Wijermans, Stephen D Nimer, Antonio Pinto, Miloslav Beran, Theo M de Witte, Richard M Stone,[...]. Blood 2006
16

Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
15

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
Rafael Bejar, Kristen E Stevenson, Bennett A Caughey, Omar Abdel-Wahab, David P Steensma, Naomi Galili, Azra Raza, Hagop Kantarjian, Ross L Levine, Donna Neuberg,[...]. J Clin Oncol 2012
321
14

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
Uwe Platzbecker, Ulrich Germing, Katharina S Götze, Philipp Kiewe, Karin Mayer, Jörg Chromik, Markus Radsak, Thomas Wolff, Xiaosha Zhang, Abderrahmane Laadem,[...]. Lancet Oncol 2017
145
14

International scoring system for evaluating prognosis in myelodysplastic syndromes.
P Greenberg, C Cox, M M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, D Oscier,[...]. Blood 1997
14

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
Luca Malcovati, Ulrich Germing, Andrea Kuendgen, Matteo G Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Aristoteles Giagounidis, Barbara Hildebrandt, Paolo Bernasconi, Sabine Knipp,[...]. J Clin Oncol 2007
728
14

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca Malcovati,[...]. Nat Med 2020
61
22

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
M J Walter, L Ding, D Shen, J Shao, M Grillot, M McLellan, R Fulton, H Schmidt, J Kalicki-Veizer, M O'Laughlin,[...]. Leukemia 2011
381
13

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
778
13

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Luca Malcovati, Elli Papaemmanuil, David T Bowen, Jacqueline Boultwood, Matteo G Della Porta, Cristiana Pascutto, Erica Travaglino, Michael J Groves, Anna L Godfrey, Ilaria Ambaglio,[...]. Blood 2011
332
13

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Luca Malcovati, Kristen Stevenson, Elli Papaemmanuil, Donna Neuberg, Rafael Bejar, Jacqueline Boultwood, David T Bowen, Peter J Campbell, Benjamin L Ebert, Pierre Fenaux,[...]. Blood 2020
41
31

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Gudrun Göhring, Anette Hedlund, Robert Hast, Brigitte Schlegelberger, Anna Porwit,[...]. J Clin Oncol 2011
313
12

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
Detlef Haase, Kristen E Stevenson, Donna Neuberg, Jaroslaw P Maciejewski, Aziz Nazha, Mikkael A Sekeres, Benjamin L Ebert, Guillermo Garcia-Manero, Claudia Haferlach, Torsten Haferlach,[...]. Leukemia 2019
63
19

The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
Adam S Sperling, Christopher J Gibson, Benjamin L Ebert. Nat Rev Cancer 2017
274
12

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
928
12

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
Luca Malcovati, Eva Hellström-Lindberg, David Bowen, Lionel Adès, Jaroslav Cermak, Consuelo Del Cañizo, Matteo G Della Porta, Pierre Fenaux, Norbert Gattermann, Ulrich Germing,[...]. Blood 2013
386
12

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
12

TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.
Austin G Kulasekararaj, Alexander E Smith, Syed A Mian, Azim M Mohamedali, Pramila Krishnamurthy, Nicholas C Lea, Joop Gäken, Coralie Pennaneach, Robin Ireland, Barbara Czepulkowski,[...]. Br J Haematol 2013
169
11

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
John S Welch, Allegra A Petti, Christopher A Miller, Catrina C Fronick, Michelle O'Laughlin, Robert S Fulton, Richard K Wilson, Jack D Baty, Eric J Duncavage, Bevan Tandon,[...]. N Engl J Med 2016
410
11

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.
Alan List, Gordon Dewald, John Bennett, Aristotle Giagounidis, Azra Raza, Eric Feldman, Bayard Powell, Peter Greenberg, Deborah Thomas, Richard Stone,[...]. N Engl J Med 2006
902
11

Genetics of MDS.
Seishi Ogawa. Blood 2019
83
13

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
Rafael Bejar, Kristen E Stevenson, Bennett Caughey, R Coleman Lindsley, Brenton G Mar, Petar Stojanov, Gad Getz, David P Steensma, Jerome Ritz, Robert Soiffer,[...]. J Clin Oncol 2014
253
11

Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Véronique Gelsi-Boyer, Manja Meggendorfer, Margot Morabito, Céline Berthon, Lionel Adès, Pierre Fenaux, Odile Beyne-Rauzy,[...]. J Clin Oncol 2013
337
11

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.
Thomas Prébet, Steven D Gore, Benjamin Esterni, Claude Gardin, Raphael Itzykson, Sylvain Thepot, François Dreyfus, Odile Beyne Rauzy, Christian Recher, Lionel Adès,[...]. J Clin Oncol 2011
294
11

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
D A Sallman, R Komrokji, C Vaupel, T Cluzeau, S M Geyer, K L McGraw, N H Al Ali, J Lancet, M J McGinniss, S Nahas,[...]. Leukemia 2016
98
10

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
R Itzykson, O Kosmider, T Cluzeau, V Mansat-De Mas, F Dreyfus, O Beyne-Rauzy, B Quesnel, N Vey, V Gelsi-Boyer, S Raynaud,[...]. Leukemia 2011
343
10

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Peter L Greenberg, Richard M Stone, Aref Al-Kali, Stefan K Barta, Rafael Bejar, John M Bennett, Hetty Carraway, Carlos M De Castro, H Joachim Deeg, Amy E DeZern,[...]. J Natl Compr Canc Netw 2017
181
10

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Julie Schanz, Heinz Tüchler, Francesc Solé, Mar Mallo, Elisa Luño, José Cervera, Isabel Granada, Barbara Hildebrandt, Marilyn L Slovak, Kazuma Ohyashiki,[...]. J Clin Oncol 2012
393
10


Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Ronan Swords, Robert H Collins, Gabriel N Mannis, Daniel A Pollyea,[...]. N Engl J Med 2018
540
10

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
Theo de Witte, David Bowen, Marie Robin, Luca Malcovati, Dietger Niederwieser, Ibrahim Yakoub-Agha, Ghulam J Mufti, Pierre Fenaux, Guillermo Sanz, Rodrigo Martino,[...]. Blood 2017
144
10

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Omar Abdel-Wahab, Mazhar Adli, Lindsay M LaFave, Jie Gao, Todd Hricik, Alan H Shih, Suveg Pandey, Jay P Patel, Young Rock Chung, Richard Koche,[...]. Cancer Cell 2012
367
10

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.
Valeria Santini, Antonio Almeida, Aristoteles Giagounidis, Stefanie Gröpper, Anna Jonasova, Norbert Vey, Ghulam J Mufti, Rena Buckstein, Moshe Mittelman, Uwe Platzbecker,[...]. J Clin Oncol 2016
124
10

Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.